Free Trial

Guided Therapeutics (GTHP) Short Interest Ratio & Short Volume

Guided Therapeutics logo
$0.10 0.00 (0.00%)
As of 03/31/2025

Guided Therapeutics Short Interest Data

Guided Therapeutics (GTHP) has a short interest of 13,800 shares, representing 0.06% of the float (the number of shares available for trading by the public). This marks a 40.82% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 12,867 shares to cover all short positions.

Current Short Interest
13,800 shares
Previous Short Interest
9,800 shares
Change Vs. Previous Month
+40.82%
Dollar Volume Sold Short
$1,656.00
Short Interest Ratio
0.5 Days to Cover
Last Record Date
February 15, 2025
Outstanding Shares
77,968,000 shares
Short Percent of Float
0.06%
Today's Trading Volume
1 shares
Average Trading Volume
12,867 shares
Today's Volume Vs. Average
0%
Short Selling Guided Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Guided Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GTHP Short Interest Over Time

GTHP Days to Cover Over Time

GTHP Percentage of Float Shorted Over Time

Remove Ads

Guided Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/202513,800 shares $1,656.00 +40.8%0.1%0.5 $0.12
1/31/20259,800 shares $1,274.00 +25.6%N/A0.3 $0.13
1/15/20257,800 shares $1,113.45 No ChangeN/A0.8 $0.14
12/31/20247,800 shares $1,170.00 No ChangeN/A0.2 $0.15
11/15/2024400 shares $68.00 -96.7%N/A0 $0.17
10/31/202412,000 shares $2,400.00 -2.4%N/A0.2 $0.20
10/15/202412,300 shares $1,723.23 -6.1%N/A4.7 $0.14
9/30/202413,100 shares $2,292.50 +36.5%N/A1.4 $0.18
9/15/20249,600 shares $1,824.00 +146.2%N/A1 $0.19
8/31/20243,900 shares $538.20 +1,200.0%N/A0.3 $0.14
8/15/2024300 shares $35.37 -72.7%N/A0 $0.12
7/31/20241,100 shares $132.00 -38.9%N/A0.1 $0.12
7/15/20241,800 shares $239.28 No ChangeN/A0 $0.13
6/15/20242,000 shares $280.00 -52.4%N/A0 $0.14
5/31/20244,200 shares $420.00 -71.0%N/A0.2 $0.10
5/15/202414,500 shares $1,160.00 +137.7%N/A0.1 $0.08
4/30/20246,100 shares $664.90 -77.2%N/A0.5 $0.11
4/15/202426,700 shares $2,563.20 +256.0%N/A0.9 $0.10
3/31/20247,500 shares $866.25 No ChangeN/A0.2 $0.12
2/29/20246,400 shares $918.40 +392.3%N/A0.1 $0.14
2/15/20241,300 shares $187.33 No ChangeN/A0 $0.14
1/15/20241,300 shares $184.60 No ChangeN/A0.1 $0.14
12/31/20231,300 shares $199.55 -45.8%N/A0 $0.15
12/15/20232,400 shares $453.60 +242.9%N/A0.1 $0.19
11/30/2023700 shares $94.50 -70.8%N/A0 $0.14
11/15/20232,400 shares $323.40 -64.2%N/A0.1 $0.13
10/31/20236,700 shares $1,005.00 No ChangeN/A0.2 $0.15
9/15/20234,900 shares $686.00 -53.8%N/A0.3 $0.14
8/31/202310,600 shares $1,590.00 -33.8%N/A0.2 $0.15
8/15/202316,000 shares $2,161.60 -0.6%N/A0.6 $0.14
7/31/202316,100 shares $2,334.50 +26.8%N/A0.7 $0.15
7/15/202312,700 shares $2,667.00 +32.3%N/A1.3 $0.21
6/30/20239,600 shares $2,160.00 +47.7%N/A0.2 $0.23
6/15/20236,500 shares $1,040.00 -55.5%N/A0 $0.16
5/31/202314,600 shares $2,774.00 +89.6%N/A1.2 $0.19
5/15/20237,700 shares $1,309.00 -56.7%N/A0.1 $0.17
4/30/202317,800 shares $4,272.00 +17,700.0%N/A0.8 $0.24
4/15/2023100 shares $28.00 -96.9%N/A0 $0.28
3/31/20233,200 shares $736.00 +18.5%N/A0.1 $0.23
3/15/20232,700 shares $796.23 +2,600.0%N/A0.9 $0.29
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)

We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.

But something even more spectacular is bound to happen. And those who know what to expect could make
2/28/2023100 shares $29.00 -95.7%N/A0 $0.29
2/15/20232,300 shares $765.90 +76.9%N/A0.1 $0.33
1/31/20231,300 shares $450.32 No ChangeN/A0.1 $0.35
12/30/20221,200 shares $360.00 -93.9%N/A0 $0.30
12/15/202219,500 shares $6,431.10 -21.4%N/A2.9 $0.33
11/30/202224,800 shares $8,665.12 +13.2%N/A2.5 $0.35
11/15/202221,900 shares $6,132.00 +10.6%N/A1 $0.28
10/31/202219,800 shares $5,940.00 -2.0%N/A0.8 $0.30
10/15/202220,200 shares $9,090.00 -7.8%N/A3.5 $0.45
9/30/202221,900 shares $11,169.00 +10.6%N/A2.3 $0.51
9/15/202219,800 shares $10,543.50 No ChangeN/A2.8 $0.53
8/31/202219,800 shares $9,702.00 -1.5%N/A6.4 $0.49
8/15/202220,100 shares $11,658.00 +133.7%N/A2.4 $0.58
7/31/20228,600 shares $4,472.00 +855.6%N/A1 $0.52
7/15/2022900 shares $512.28 No ChangeN/A0 $0.57
6/15/2022900 shares $427.95 -76.3%N/A0.1 $0.48
5/31/20223,800 shares $1,938.00 +192.3%N/A0.1 $0.51
5/15/20221,300 shares $715.00 No ChangeN/A0.1 $0.55
3/31/2022300 shares $195.00 -83.3%N/A0 $0.65
3/15/20221,800 shares $918.00 +1,700.0%N/A0.2 $0.51
2/28/2022100 shares $52.50 No ChangeN/A0 $0.53
2/15/2022100 shares $62.50 No ChangeN/A0 $0.63
1/31/2022100 shares $60.00 -75.0%N/A0 $0.60
1/15/2022400 shares $240.00 +300.0%N/A0 $0.60
12/31/2021100 shares $58.02 No ChangeN/A0 $0.58
12/15/2021100 shares $64.94 No ChangeN/A0 $0.65
11/30/2021100 shares $67.50 -50.0%N/A0 $0.68
11/15/2021200 shares $114.02 +100.0%N/A0 $0.57
10/29/2021100 shares $57.00 No ChangeN/A0 $0.57
10/15/2021100 shares $54.00 No ChangeN/A0 $0.54
9/30/2021100 shares $55.99 -98.2%N/A0 $0.56
9/15/20215,400 shares $3,345.30 +17.4%N/A0.4 $0.62
8/31/20214,600 shares $2,529.54 +475.0%N/A0.2 $0.55
8/13/2021800 shares $410.16 +700.0%N/A0 $0.51
7/30/2021100 shares $59.00 -95.7%N/A0 $0.59
7/15/20212,300 shares $1,426.00 +35.3%N/A0.3 $0.62
6/30/20211,700 shares $1,071.00 +240.0%N/A0.2 $0.63
6/15/2021500 shares $331.30 +400.0%N/A0 $0.66
5/28/2021100 shares $59.25 No ChangeN/A0 $0.59
5/14/2021100 shares $64.00 -75.0%N/A0 $0.64
4/30/2021400 shares $276.04 No ChangeN/A0 $0.69
3/15/2021100 shares $75.00 -92.3%N/A0 $0.75
2/26/20211,300 shares $1,157.00 -81.4%N/A0 $0.89
2/12/20217,000 shares $3,500.00 -41.2%N/A0.3 $0.50
1/29/202111,900 shares $4,998.00 +5,850.0%N/A0.3 $0.42
1/15/202113,800 shares $5,533.80 +294.3%N/A0.2 $0.40
12/31/20206,600 shares $2,171.40 -52.2%N/A0.5 $0.33
12/15/202013,800 shares $2,497.80 +294.3%N/A0.2 $0.18
11/30/20203,500 shares $665.00 -78.7%N/A0.1 $0.19
11/15/202016,400 shares $4,608.40 +1,540.0%N/A0.6 $0.28
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)

We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.

But something even more spectacular is bound to happen. And those who know what to expect could make
10/30/20201,000 shares $363.00 +11.1%N/A0.1 $0.36
10/15/2020900 shares $279.18 +125.0%N/A0.2 $0.31
9/30/2020400 shares $148.00 -91.8%N/A0.1 $0.37
9/15/20204,900 shares $1,813.00 -70.8%N/A0.5 $0.37

GTHP Short Interest - Frequently Asked Questions

What is Guided Therapeutics' current short interest?

Short interest is the volume of Guided Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 15th, investors have sold 13,800 shares of GTHP short. 0.06% of Guided Therapeutics' shares are currently sold short. Learn More on Guided Therapeutics' current short interest.

What is a good short interest percentage for Guided Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.06% of Guided Therapeutics' floating shares are currently sold short.

Is Guided Therapeutics' short interest increasing or decreasing?

Guided Therapeutics saw a increase in short interest in February. As of February 15th, there was short interest totaling 13,800 shares, an increase of 40.8% from the previous total of 9,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Guided Therapeutics' short interest compare to its competitors?

0.06% of Guided Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Guided Therapeutics: Spectral AI, Inc. (8.39%), Vaso Co. (0.03%), NEXGEL, Inc. (2.00%), ReWalk Robotics Ltd. (26.84%), Beyond Air, Inc. (2.46%), Vivos Therapeutics, Inc. (5.42%), Nephros, Inc. (0.21%), Allurion Technologies Inc. (3.08%), QT Imaging Holdings, Inc. (1.89%), IRIDEX Co. (2.18%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks.

What does it mean to sell short Guided Therapeutics stock?

Short selling GTHP is an investing strategy that aims to generate trading profit from Guided Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Guided Therapeutics?

A short squeeze for Guided Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GTHP, which in turn drives the price of the stock up even further.

How often is Guided Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GTHP, twice per month. The most recent reporting period available is February, 15 2025.




This page (OTCMKTS:GTHP) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners